During a recent trial, researchers surveyed more than 2,000 men about their sexual health. While interviewing the participants, the investigators also monitored the men for depression-related symptoms.

The findings showed that the participants who were diagnosed with ED and depression were more likely to suffer from cardiovascular complications, which could lead to a higher mortality rate. Also, the researchers found that taking antidepressants wasn’t linked to the increased risk of developing these health problems.

Irwin Goldstein, editor-in-chief of the journal and director of sexual medicine at Alvarado Hospital in San Diego, stated that "the broader concept of the sexual medicine problem [is] no longer being just about a man’s performance in the bedroom, but about his psychological mood and his cardiovascular health." He added that "this is a valid reason for a woman to encourage her partner to seek help for his erectile dysfunction."

While depression symptoms have been linked to developing ED, the team concluded that physicians who treat men with ED should also screen their patients for the mood disorder to improve cardiac health.

Currently, an estimated 30 million men in the United States have been diagnosed with ED, according to the Minnesota Men’s Health Center.

Teams of researchers will incorporate botanical mixtures into their trials, which could lead to more effective and safer therapies for cancer patients. Also, by using natural compounds, New Earth BioMed hopes advancements in treatments will result in fewer side effects.

John Boik, president of the company, stated that "recent advances in bioinformatics, analytical technology and other related fields are strongly pointing to the concept that activities of a cell are dictated by a complex and dynamic internal web of protein interactions." He added that "this new screening program is representative of a new breed of drug discovery initiatives brought about through an evolution in biological understanding."

Advancements in natural alternatives for cancer therapies with fewer side effects may benefit those receiving treatments for these diseases. For example, the American Cancer Society reports that patients who undergo radiation therapy can experience fatigue, hair loss, skin problems, digestive problems, shortness of breath and negative psychological effects.

During a recent trial, rats were genetically altered to show signs of the digestive disease, and then injected with prostaglandin D2, the newly discovered compound.

The researchers discovered that the higher chemical level reversed some of the damage associated with ulcerative colitis. Also, the results of the study showed that prostaglandin D2 elongated stages of remission.

Because of the positive results found during the animal trial, the team concluded that these findings may contribute to developing drugs and treatments for humans.

John Wallace, co-author of the trial, stated "the levels of prostaglandin D2 were only elevated in those patients in long-term remission, and that suggests it is a key factor in preventing new episodes of ulcerative colitis." He added that "it is entirely possible our findings could extend to Crohn’s disease, [which is another form of irritable bowel syndrome], as well."

According to the National Digestive Diseases Information Clearinghouse, in 2008, an estimated 82,000 people in the U.S. were hospitalized for ulcerative colitis.

Previous studies using animals have proven that consuming coffee could lower the risk of being diagnosed with type 2 diabetes.

Using two groups of mice, a team of researchers gave the animals either water or coffee.

The results of the study showed the mice that drank coffee had improved sensitivity to insulin and better prevention against the development of high-blood sugar levels. The team discovered that coffee consumption could help reduce inflammation of the liver, which may also lower the risks of developing diabetes.

The scientists concluded that other trials have also showed that caffeine may be "one of the most effective antidiabetic compounds in coffee."

In addition to preventing diabetes, coffee drinkers can also lower the risks of developing Parkinson’s disease, as a recent report by researchers at the University of Porto in Portugal found that consuming the beverage reduces the chance of being diagnosed with the illness by 25 percent.

Psoriatic arthritis is a joint condition that affects the fingers or toes and leads to stiffness and pain. Individuals who develop psoriasis, a skin-related disease, could be at a higher risk of developing psoriatic arthritis.

In order to better understand how excessive weight gain could contribute to developing this type of arthritis, more than 900 individuals were enrolled in a six-year study. Of the group, 51 percent had been diagnosed with psoriatic arthritis and 27 percent had psoriasis.

The researchers then screened the body mass index (BMI) of each participant, and found that an unhealthy BMI at age 18 years was a sign of psoriatic arthritis later in life.

The results showed that 20 percent of overweight or obese participants developed psoriatic arthritis by age 45, while 20 percent of healthy-BMI individuals showed signs of joint problems by age 48.

"Patients with psoriasis represent a unique opportunity to identify individuals at very high risk of developing [psoriatic arthritis]," the authors stated. They added that "to determine which patients are at greatest risk, it is essential that risk factors be identified using robust epidemiologic approaches."

Approximately 7.5 million Americans have been diagnosed with psoriatic arthritis, and of this population, 2.2 percent suffer from psorasis, the Natonal Psorasis Foundation reports.

During a 20-year study conducted at the University of California in San Francisco, more than 3,200 individuals aged 18 to 30 years had their cholesterol measured. The researchers also examined each participant’s coronary artery calcium, which is plaque that accumulates in the arteries, by using CT scans.

The team discovered that those who recorded unhealthy levels of bad cholesterol in their bodies also suffered from an increase in coronary calcium, which is a cause of coronary heart disease. The results of the study also showed that the longer a person suffered increased measurements of bad cholesterol, the more likely they were to be diagnosed with related cardiovascular problems.

"We don’t usually worry too much about heart disease risk until a person is in middle age because it’s rare to have a heart attack in young adulthood," said Mark J. Pletcher, lead author of the trial. He added that "however, our evidence shows that young adulthood is an important time because lasting damage already starts to accumulate at this age."

One of the most common heart problems, coronary heart disease was the cause of more 445,000 deaths in the U.S. during 2005, according to the Centers for Disease Control and Prevention.

Previous trials have found that women who have already experienced menopause are among the most common high-risk populations. In order to better understand the connection between low hormone levels and this health problem, researchers enrolled 60 women aged 31 to 80 years who had been diagnosed with aneurysms in a two-year study.

The team then surveyed the participants about their gynecologic history and hormone treatment use, and compared their responses to a control group of more than 4,600 women.

The researchers discovered that approximately 78 percent of the control group reported the use of oral contraceptives, while 60 percent of the aneurysm group had used these medications. Also, an estimated 45 percent of the aneurysm-free women used HRT, while only 24 percent of the study group had a history of HRT.

Michael Chen, co-author of the study, stated that these findings "support our hypothesis that drops in estrogen that occur in menstruation and particularly at menopause may explain why cerebral aneurysms are more frequently found in women."

Patients who have been diagnosed with a brain aneurysm have a 15 to 20 percent chance of developing at least one more during their lifetime, The Aneurysm and AVM Foundation reports.

During a recent trial, a team of researchers enrolled more than 8,700 women aged 65 to 79 years in order to determine how excessive weight gain may affect cognitive function. Investigators then scored each participant on a memory test, excluding certain components, such as diabetes, heart disease and stroke.

The results of the study showed that women who carried more weight on their hips than their waist were more likely to develop cognitive degenerate disorders.

Diana Kerwin, assistant professor of medicine and a physician at Northwestern Medicine, stated that "the message is obesity and a higher body mass index (BMI) are not good for your cognition and your memory." She added that "while the women’s scores were still in the normal range, the added weight definitely had a detrimental effect."

The Texas Department of State Health Services reports that one in eight people aged 65 years and older are diagnosed with Alzheimer’s disease, which is the most common form of dementia.

By improving blood sugar level control, researchers may be able to slow the development of diabetic retinopathy, which is retina damage caused by long-term diabetes.

In order to better understand this vision disorder, investigators enrolled 10,251 type 2 diabetes patients in the the Action to Control Cardiovascular Risk in Diabetes Eye Study. Participants were selected because they were at a high risk of suffering heart problems.

The team used treatments that could improve cardiovascular health in diabetes patients, including control of blood sugar, blood pressure and good and bad cholesterol in the blood.

The results showed that using these methods over the course of four years could slow diabetic retinopathy progression by approximately 34 percent.

Walter T. Ambrosius, lead author of the study, stated that cardiovascular problems in diabetics can "result in problems with the kidneys and amputation of toes and feet, and the only place that you can directly observe the microvasculature is in the back of the eyes." He added that "the eyes [are] potentially an indicator of what is happening in other parts of the body."

Approximately 1.6 million Americans aged 20 years and older are diagnosed with diabetes each year, the American Diabetes Association reports.

During a recent trial, researchers monitored the use of phosphodiesterase type 5 inhibitors (PDE5is), a type of ED treatment, in a total of 11,889 sexually active men. The team then analyzed the results to determine how many men went to their primary care doctors for treatments for the disorder.

The investigators discovered that approximately three out of every 10 men who participated in the study had acquired PDE5is without consulting a physician.

Mike Kirby, author of the study, stated that these men may "not only expose themselves to the risks of using unapproved and uncontrolled products, but also miss important information on product use and contraindications." He added that they don’t "receive appropriate health information regarding the importance of medical follow-up for unrecognised cardiovascular disease often seen in combination with ED."

Currently, approximately 30 million American men have been diagnosed with ED, the Minnesota Men’s Health Center report.